Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed...
Editorial
Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
Marc G. Denis, Guillaume Herbreteau, Elvire Pons-Tostivint